한국형 양극성 장애 약물치료 알고리듬：개정 및 향후 방향 = Korean Medication Algorithm for Bipolar Disorder：Revision and Further Suggestion

다국어 초록 (Multilingual Abstract)

The algorithms and guidelines are a synthesis of current scientific evidences with clinical issues of safety and tolerability. It is inevitable that pharmacological strategies of psychiatric treatment have to be based on evidence-based medicine. The first Korean Medication Algorithm for Bipolar Disorder was developed from the information and opinions gathered by wide surveys to Korean psychiatrists and then, in the first time, its feasibility study was done. The problems on appropriateness of the shift of step, full education of algorithm administration and procedure before implementation, and easy applicability of measuring scales were found. These problems must be fully considered for algorithm implementation in the near future. Rapid updates on new evidences of therapeutic effects of drugs and recent trends of diagnostic concepts about bipolar disorder may justify revision of the medication algorithm. Especially, addition of widespread use of novel antipsychotics in all phases of illness, evidences of new anticonvulsants' effects, and change of strategies in the acute depression and maintenance treatments will have to be considered. Moreover, modification of questionnaire for algorithm revision will be needed in the aspect of easy implementation.

참고문헌 (Reference)

1 "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(IV)삶의 질" 16 : 396-405, 2005

2 "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(III)치료반응과 내약성" 16 : 292-30, 2005

3 "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(II)약물의 선택" 16 : 285-291, 2005

4 "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(I)전반적 평가" 16 : 225-233, 2005

5 "한국형 알고리듬 개발 사업 내용과 기본 계획, 조직구성, 알고리듬 개발의 기본 원칙, 개발방법, 제한점 및 사용시 주의점" 13 : 30-36, 2002

6 "주요 정신질환의 약물치료에 대한 한국형 알고리듬 개발 알고리듬과 임상지침서의 장 단점 및 개발과 관련된 일반사항" 18-29

7 "주요 정신질환의 약물치료에 대한 한국형 알고리듬 개발"

8 "양극성 장애의 한국형 약물치료 알고리듬(IV)급속 순환" 115 : 44-50, 2004

9 "양극성 장애의 한국형 약물치료 알고리듬(III)우울 삽화" 14 : 336-346, 2003

10 "양극성 장애의 한국형 약물치료 알고리듬(II)조증 삽화" 14 : 223-230, 2003

11 "양극성 장애의 한국형 약물치료 알고리듬(I)" 13 : 205-21, 2002

12 "양극성 장애 약물치료에 대한 한국형 알고리듬 지침서" 2002

13 "uetiapine monotherapy for acute mania associated with bipolar disorder (STAMP 1 and STAMP 2)." San Francisco, Calif 2003

14 Sachs G, "medication treatment of bipolar disorder 20" 1-104,

15 "Ziprasidone in the treatment of acute bipolar mania" 741-748,

16 "Ziprasidone in acute bipolar mania:a 21-day randomized,double-blind,place-bo-controlled replication trial" 25 : 301-310, 2005

17 Can J Psychiatry 197, "The treatment of bipolar disorder review of the litera-ture"

18 "The Texas implementation of medica-tion algorithms:update to the algorithms for treatment of bi-polar I disorder" 66 : 870-86, 2005

19 "Texas Medication Algorithm Project:development and feasibility testing of a treatment algorithm for patients with bipolar disorder" 62 : 439-447, 2001

20 "Texas Medication Algorithm Project, phase 3 (TMAP-3) clinical results for patients with a history of mania" 64 : 370-382, 2003

21 Suppes T, "Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000" 63 : 288-29, 202

22 "Rapid-cycling bipolar di-sorder:efects of long-term treatments" 108 : 4-14, 2003

23 "Rapid antimanic effect of risperidone mo-notherapy:a 3-wek multicenter,double-blind,placebo-cont-rolled trial" 161 : 1057-1065, 2004

24 "Rapid and non-rapid cycling bipolar disorder:a metaanalysis of clinical studies" 64 : 1483-1494, 2003

25 Levine J, "Psychotropic drug prescription patterns among patients with bipolar I disorder" 2 : 120-130, 20

26 "Practice guideline for the treatment of patients with bipolar disorder" 151 : 1-36, 1994

27 "Olanzapine versus placebo in the treat-ment of acute mania" 56 : 702-709, 19

28 "Olanzapine versus lithium in the mainte-nance treatment of bipolar disorder" 1281-1290,

29 Calabrese JR, "International Consensus Group on Bipolar I Depres-sion Treatment Guidelines" 65 : 571-579, 2004

30 "Extended-release carbama-zepine capsules as monotherapy for acute mania in bipolar di-sorder" a multicenter 323-30,

31 Mellman TA, "Evidence-based pharmacologic treatment for people with severe mental illnes:a focus on guidelines and algorithms" 52 : 619-625, 201

32 "Eficacy of olanzapine and olanzapine-fluoxetine combina-tion in the treatment of bipolar I depression" 60 : 1079-1088, 203

33 "Efficacy of olanzapine in acute bipolar mania" 57 : 841-849, 200

34 "Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies." 3 5-69, 2005

35 CAN-, "Canadian Network for Mood and Anxiety Treatments"

36 Royal Australian, "Austra-lian and New Zealand clinical practice guidelines for the treatment of bipolar disorder" 38 : 280-305, 204

37 "An open-label study of ami-sulpride in the treatment of mania" 66 : 575-578, 2005

38 "A randomized,double-blind,placebo-controlled trial of quetiapine in the treatment of bipolar I or I depression" 162 : 1351-1360, 2005

39 "A placebo-controlled,double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania" 160 : 1651-1658, 2003

40 "A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders" 20 : 607-614, 2000

41 "A placebo-controlled 18-month trial of la-motrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder" 60 : 392-40, 203

42 "A placebo-controled 18-month trial of lamotrigine and lithium maintenance treatment in recently de-presed patients with bipolar I disorder" 64 : 1013-1024, 2003

43 Cabana MD, "A framework for improvement" 1458-19 1465,

44 "A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid cycling bipolar disorder" 61 : 841-850, 2000

45 "A double-blind placebo-controled study of lamotri-gine monotherapy in outpatients with bipolar I depresion" 60 : 79-8, 199

46 "A 20-month double-blind, mainte-nance trial of lithium vs. divalproex in rapid cycling bipolar disorder." 2005